Health & Fitness
Health and Fitness
Health and Fitness 
Mon, July 13, 2009
Sun, July 12, 2009
Fri, July 10, 2009
Thu, July 9, 2009
IDenta Corp.: International Drug and Explosives Detection Firm IDenta Corp. Announces First Placement of New General Screening
JERUSALEM--(Marketwire - July 9, 2009) - IDenta Corp. (
CEO Yaacov Shoham states, "The response to this new test kit has been overwhelming and to already have it on the shelves of some stores after announcing it in February shows the interest that has been generated by this all inclusive kit."
The new General Screening Drug Test Kit features the high standards of IDenta's different products: No false positives, easy to use, reliable, safe, works on trace amounts, inexpensive, environmentally green.
This new kit is currently being manufactured and is intended for law enforcement agencies, but is especially directed to the retail-consumer market (worried parents, schools, working place, etc.).
This one kit will give a positive response for the following 19 types of known drugs: Heroin, Cocaine/Crack, Methamphetamine, Amphetamine, MDMA, Ephedrine, LSD, Methadone, Ketamine, PCP, Pentazocine, Propoxyphene, PMA, Oxycodone, AMT, DMT, Mescaline, Pethidine.
The use of it is very simple, breaking only up to 2 ampoules, and getting the positive color that will indicate the presence of one of the mentioned illicit drugs.
No positive color developed after the two broken ampoules, absolutely no illicit drug is present.
The chemical composition for the new detector is novel and unique.
ABOUT IDENTA
Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.
Information concerning IDenta's entire product line may be found at [ www.IDenta.biz ] or [ fpi@drugsdetector.com ]
DISCLAIMER
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, [ fpi@drugsdetector.com ], [ www.identa.biz ].